| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 673.772 | 794.518 | 2.813.118 | 2.498.914 | 3.026.685 |
| Total Income - EUR | - | - | - | - | - | 685.406 | 794.521 | 2.816.631 | 2.508.806 | 3.070.040 |
| Total Expenses - EUR | - | - | - | - | - | 662.510 | 729.047 | 2.636.051 | 2.344.190 | 2.829.481 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 22.896 | 65.474 | 180.580 | 164.615 | 240.560 |
| Net Profit/Loss - EUR | - | - | - | - | - | 16.740 | 58.085 | 155.110 | 139.547 | 203.265 |
| Employees | - | - | - | - | - | 1 | 1 | 1 | 0 | 1 |
Check the financial reports for the company - Medpolimer S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 34 | 2.001 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | 70.667 | 197.100 | 259.825 | 868.883 | 1.035.693 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 70.509 | 190.573 | 259.496 | 778.705 | 795.496 |
| Cash | - | - | - | - | - | 158 | 6.528 | 328 | 90.178 | 240.197 |
| Shareholders Funds | - | - | - | - | - | 21.908 | 63.957 | 163.221 | 148.038 | 211.708 |
| Social Capital | - | - | - | - | - | 5.168 | 5.054 | 7.097 | 7.076 | 7.036 |
| Debts | - | - | - | - | - | 53.385 | 135.335 | 97.176 | 720.943 | 824.022 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4675 - 4675" | |||||||||
| CAEN Financial Year |
4675
|
|||||||||
Comments - Medpolimer S.r.l.